Cognitive impairment is frequently observed in patients with mood disorder, affecting around two-thirds of patients with depression and predicting poor response to treatment. We investigated whether cognitive impairment should be considered a core feature of depression that may be a valuable target for future pharmacological treatments....
Victoria Macdonald on Health and Social Care Channel 4 News 27 April 2013...
Cambridge Cognition Holdings plc, (AIM: COG), which specialises in computerised neuropsychological tests including those enabling the early detection of dementia, welcomes the NHS Commissioning Board specifications for the four new directed enhanced services (‘DES’) that will be offered to GP practices in 2013/14, which prioritises, amongst other conditions, the timely diagnosis and support for people with dementia. ...
Cambridge Cognition Holdings plc, (AIM: COG), which specialises in computerised neuropsychological tests including those enabling the early detection of dementia, announces the commencement, at 08.00 UK time this morning, of dealings in its Ordinary Shares on AIM, a market operated by the London Stock Exchange plc....
Copyright ©2013 Cambridge Cognition Ltd. All rights reserved.
Registered in England and Wales; Company no. 4338746
Cookies | Press | Privacy | Terms of Use | Sitemap 
